COREX to Exhibit at TCIS Africa 2026 in Pretoria

COREX Business Development Manager Kayla van den Bergh will represent the company at TCIS Africa 2026, taking place May 4-5 at the CSIR International Convention Centre in Pretoria, South Africa.

The conference brings together pharmaceutical industry professionals, clinical research organizations, regulatory authorities, and logistics providers from across the African continent to discuss advancing clinical trial capabilities and pharmaceutical access throughout Africa.

Strategic Focus on African Markets

For COREX, participation in TCIS Africa represents a strategic commitment to supporting clinical research growth across African markets. Kayla van den Bergh's extensive experience in South African pharmaceutical logistics, combined with COREX's global clinical trial supply expertise, positions the company well for meaningful engagement with African pharmaceutical stakeholders.

Clinical Trial Supply Expertise

TCIS Africa 2026 focuses on practical challenges facing clinical research across the continent, including regulatory harmonisation efforts, supply chain infrastructure development, patient recruitment strategies, and building sustainable clinical research capabilities.

COREX's participation emphasizes the company's experience in managing complex international clinical trial logistics across diverse regulatory environments and challenging geographical markets.

Meeting COREX at TCIS Africa

Conference attendees can find Kayla van den Bergh at Booth 9&10 throughout the two-day event. She will be available to discuss COREX's clinical trial logistics capabilities, international supply chain solutions, and how specialized pharmaceutical logistics can support expanding clinical research activities across African markets.

For more information about TCIS Africa 2026: https://tcisafrica.org

Back to the list